Perspective Therapeutics, Inc.
CATX- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000728387
In the last 90 days, Perspective Therapeutics, Inc. insiders filed 0 open-market purchases and 5 sales; 131 institutions reported holding it in 13F filings for Q2 2026, worth $297.6M in total; no superinvestor holds it.
13F holders, Q3 2024
Institutional positions in Perspective Therapeutics, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 127
- +23 vs. Q2 2024
- Shares held
- 49.1M
- +13.9M (+39.6%) vs. Q2 2024
- Total value
- $654.9M
- +$304.8M (+87.0%) vs. Q2 2024
- New holders
- 42
- 47 more added
- Sold out
- 19
- 23 more reduced
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CATX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 131 | $297.6M |
| Q1 2026 | 138 | $333.1M |
| Q4 2025 | 117 | $105.0M |
| Q3 2025 | 105 | $150.1M |
| Q2 2025 | 98 | $146.3M |
| Q1 2025 | 112 | $96.4M |
| Q4 2024 | 135 | $150.7M |
| Q3 2024 | 127 | $654.9M |
| Q2 2024 | 105 | $384.9M |
| Q1 2024 | 104 | $294.6M |
| Q4 2023 | 52 | $14.7M |
| Q3 2023 | 49 | $9.99M |
| Q2 2023 | 50 | $22.0M |
| Q1 2023 | 42 | $17.8M |
| Q4 2022 | 48 | $4.26M |
| Q3 2022 | 35 | $3.70M |
| Q2 2022 | 43 | $5.19M |
| Q1 2022 | 39 | $5.79M |
| Q4 2021 | 45 | $6.78M |
| Q3 2021 | 43 | $9.99M |
| Q2 2021 | 48 | $13.9M |
| Q1 2021 | 57 | $20.2M |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Perspective Therapeutics, Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Rock Springs Capital Management LP | 414,396 | $5.53M | 0.18% | +13,200+3.3% | Added |
| Charles Schwab Investment Management Inc | 433,522 | $5.79M | 0.00% | +298,778+221.7% | Added |
| Goldman Sachs Group Inc | 448,683 | $5.99M | 0.00% | +448,683 | New |
| Northern Trust Corp | 474,158 | $6.33M | 0.00% | +336,318+244.0% | Added |
| Affinity Asset Advisors, LLC | 500,000 | $6.67M | 1.04% | −50,000−9.1% | Reduced |
| ExodusPoint Capital Management, LP | 581,614 | $7.76M | 0.08% | −14,440−2.4% | Reduced |
| Sphera Funds Management Ltd. | 589,295 | $7.87M | 1.29% | −197,614−25.1% | Reduced |
| Schonfeld Strategic Advisors LLC | 591,623 | $7.90M | 0.06% | +65,823+12.5% | Added |
| Ameriprise Financial Inc | 662,496 | $8.84M | 0.00% | +662,496 | New |
| Ghost Tree Capital, LLC | 750,000 | $10.0M | 3.41% | −175,000−18.9% | Reduced |
| Adage Capital Partners GP, L.L.C. | 750,000 | $10.0M | 0.02% | +368,360+96.5% | Added |
| Nuveen Asset Management, LLC | 830,213 | $11.1M | 0.00% | +569,286+218.2% | Added |
| Paradigm Biocapital Advisors LP | 919,692 | $12.3M | 0.43% | 00.0% | Unchanged |
| Hills Bank & Trust Co | 1,027,830 | $13.7M | 1.04% | +1,027,830 | New |
| Geode Capital Management, LLC | 1,164,204 | $15.5M | 0.00% | +129,654+12.5% | Added |
| Octagon Capital Advisors LP | 1,422,224 | $19.0M | 3.04% | −158,025−10.0% | Reduced |
| Marshall Wace, LLP | 1,490,791 | $19.9M | 0.03% | +206,849+16.1% | Added |
| Nicholson Wealth Management Group, LLC | 1,602,283 | $21.4M | 17.57% | +1,602,283 | New |
| State Street Corp | 2,190,239 | $29.2M | 0.00% | +1,192,812+119.6% | Added |
| Deerfield Management Company, L.P. (Series C) | 2,817,763 | $37.6M | 0.56% | 00.0% | Unchanged |
| Vanguard Group Inc | 3,076,941 | $41.1M | 0.00% | +155,673+5.3% | Added |
| Commodore Capital LP | 3,350,000 | $44.7M | 2.79% | −1,307,345−28.1% | Reduced |
| Avidity Partners Management LP | 3,444,002 | $46.0M | 2.35% | +406,334+13.4% | Added |
| BlackRock, Inc. | 4,039,974 | $53.9M | 0.00% | +4,039,974 | New |
| Janus Henderson Group PLC | 4,799,352 | $64.0M | 0.03% | +355,685+8.0% | Added |
| FMR LLC | 5,504,822 | $73.5M | 0.00% | +5,370,392+3,994.9% | Added |
| International Assets Investment Management, LLC | 1,202 | – | – | +1,112+1,235.6% | Added |
| OrbiMed Advisors LLC | 0 | $0 | 0.00% | −492,670−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −246,558−100.0% | Sold out |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −202,572−100.0% | Sold out |
| WealthPLAN Partners, LLC | 0 | $0 | 0.00% | −169,963−100.0% | Sold out |
| Superstring Capital Management LP | 0 | $0 | 0.00% | −87,638−100.0% | Sold out |
| Winton Group Ltd | 0 | $0 | 0.00% | −84,363−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −83,346−100.0% | Sold out |
| ADAR1 Capital Management, LLC | 0 | $0 | 0.00% | −69,985−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −63,581−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −61,660−100.0% | Sold out |
| Alpine Global Management, LLC | 0 | $0 | 0.00% | −44,714−100.0% | Sold out |
| EAM Investors, LLC | 0 | $0 | 0.00% | −32,631−100.0% | Sold out |
| Voloridge Investment Management, LLC | 0 | $0 | 0.00% | −15,963−100.0% | Sold out |
| Bridgeway Capital Management, LLC | 0 | $0 | 0.00% | −13,400−100.0% | Sold out |
| Point72 (DIFC) Ltd | 0 | $0 | 0.00% | −11,842−100.0% | Sold out |
| State of Wyoming | 0 | $0 | 0.00% | −572−100.0% | Sold out |
| Lazard Asset Management LLC | 0 | $0 | 0.00% | −523−100.0% | Sold out |
| Headlands Technologies LLC | 0 | $0 | 0.00% | −152−100.0% | Sold out |
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 0 | $0 | 0.00% | −51−100.0% | Sold out |
| BlackRock Inc. | – | – | – | – | Not filed |